Use of anhydrovinblastine

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514183, 514908, 540478, 540479, 546 91, A61K 3133, A61K 4342, A61K 31485, C07D51904

Patent

active

060110414

ABSTRACT:
The present invention is particularly directed to the use of a derivative of vinblastine, 3',4'-anhydrovinblastine (AHVB), which differs from vinblastine in that it possesses a double bond at the 3',4' position of the caranthine nucleus rather than the hydroxyl group that is present in the parent structure, as an antineoplastic agent in the therapeutic treatment of cancer. Specifically, the treatment of lymphoma with 3',4'-anhydrovinblastine is disclosed.

REFERENCES:
patent: 4029663 (1977-06-01), Gutowski et al.
patent: 4144237 (1979-03-01), Kutney
patent: 4307100 (1981-12-01), Langlois et al.
Registry No. 38390-45-3, Jun. 26, 1997.
LeChevalier et al, Anticancer Res. vol. 12 p. 1794, 1992.
REmington's Pharmaceutical Sciences, 16 Edition, pp. 1518-1534, 1980.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Use of anhydrovinblastine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of anhydrovinblastine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of anhydrovinblastine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1072871

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.